Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

This study has been completed.
Sponsor:
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT00002679
First received: November 1, 1999
Last updated: August 24, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2002
  Primary Completion Date: January 2002 (Final data collection date for primary outcome measure)